EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2000

Study Completion Date

October 31, 2006

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

cilengitide

Trial Locations (10)

30322

Emory University Hospital - Atlanta, Atlanta

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48202

Henry Ford Hospital, Detroit

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

New Approaches to Brain Tumor Therapy Consortium

OTHER

NCT00006093 - EMD 121974 in Treating Patients With Progressive or Recurrent Glioma | Biotech Hunter | Biotech Hunter